News and Trends 4 Oct 2019
ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO, citing adverse market conditions caused…
Aprea Therapeutics
- Latest Posts
News and Trends 22 Mar 2017
Swedish Oncology Biotech Teams up with World Leading Cancer Center
The Swedish biotech Aprea Therapeutics has entered a new collaboration with the Memorial Sloan Kettering Cancer Center to study the…
News and Trends 26 Dec 2016
The Largest Deals, Fundraising and Exits of 2016 in European Biotech
Curious about which technologies have attracted the most cash in biotech finance this year? Here's a list of the most impressive cash…
News and Trends 12 Oct 2016
Will Aprea live up to the Hype of its €46M fundraising?
Aprea raised a huge €46M for a first-in-class drug that targets the deadliest form of ovarian cancer. The company just started Phase II…
ADVERTISEMENT
News and Trends 8 Jun 2016
12 European Biotechs which ‘stole the show’ at World most Important Cancer Meeting
Pharma and Biotech from every corner flocked to Chicago for the beginning of June. Why? It's where one of the…
News and Trends 4 Apr 2016
Biotech Environment in 2016: Reverse Engineering the Ecosystem #BES2016
BIO-Europe Spring 2016 is starting off right away with the plenary opening session. The conference was about partnering, trends and…
News and Trends 10 Mar 2016
The Largest Scandinavian Biotech Fundraising of 2016 has just been Signed
Aprea (Sweden) is not a well-know Biotech (yet), but has succeeded in raising €46M from big investors in the US…
